Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Attix Pharmaceuticals is a Canadian-based pharmaceutical company that specializes in the sourcing and distribution of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. Headquartered in Ontario, the company is a Health Canada-licensed establishment that serves as a vital link in the pharmaceutical supply chain for both human and veterinary medicine. Their core business involves providing high-quality raw materials to manufacturers, backed by comprehensive regulatory and quality assurance support. Attix maintains a global network of GMP-certified manufacturing partners to ensure a reliable supply of niche and hard-to-source ingredients. In addition to API supply, the company offers services in product development, licensing, and the commercialization of generic pharmaceuticals. By focusing on regulatory compliance and supply chain efficiency, Attix supports the pharmaceutical industry in bringing cost-effective medications to market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Attix Pharmaceuticals.